Navigation Links
Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma
Date:6/5/2008

SUNNYVALE, Calif., June 5 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced final data from a Phase 1/2 study showing a 46 percent complete response rate in patients with multiply recurrent non-Hodgkin's lymphoma (NHL) who were treated with motexafin gadolinium (MGd, Xcytrin(R)) in combination with Yttrium-90 Ibritumomab Tiuxetan (Zevalin(TM)), an approved antibody-targeted radiation therapy. The data were presented during the 10th International Conference on Malignant Lymphoma being held this week in Lugano, Switzerland.

The Phase 1/2 study was conducted in 29 patients with advanced relapsed lymphomas, including 11 patients with aggressive lymphomas. Eighty-three percent of the patients were rituximab (Rituxan(R)) refractory. Patients were treated with a standard dose of Zevalin administered with 2.5 to 5.0 mg/kg of MGd given for six days. Of 28 evaluable patients, 46 percent showed a complete response and 11 percent showed a partial response for an overall response rate of 57 percent. Rituximab refractory patients showed an overall response rate of 86 percent, with a 64 percent complete response rate and a median time to progression of 14 months. Adverse events seen were related to bone marrow suppression, an expected side effect of treatment with Zevalin.

"Motexafin gadolinium has been shown to have single agent activity in lymphoma and is synergistic with radiation therapy. This study shows a high rate of durable complete responses, especially in rituximab refractory patients," said Andrew M. Evens, D.O., M.S., Department of Hematology/Oncology, Northwestern University Feinberg School of Medicine, and lead author of the study.

Pharmacyclics has been developing MGd for use in combination
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... DUBLIN , Apr. 14, 2015 Research and ... addition of the "US Proton Therapy Outlook - ... According to the US Proton Therapy Outlook: Market Opportunities ... will be home to almost 29 such centers ... current figure. Consequently, the market will breach the Billion ...
(Date:4/20/2015)... , April 20, 2015  In its latest ... markets, the FTC announced that Cardinal Health, Inc. ... monopolized 25 local markets for the sale and ... clinics to pay inflated prices for these drugs. ... $26.8 million of ill-gotten gains and represents the ...
(Date:4/20/2015)... April 20, 2015  Ameritox,s Ingenuity Health, a leading ... presented clinical research at the National Council of Behavioral ... , showing that nearly 25 percent of the samples ... not contain the prescribed antipsychotic medication. ... ...
Breaking Medicine Technology:United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 2Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 3Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 4Cardinal Health Agrees to Pay $26.8 Million to Settle Charges It Monopolized 25 Markets for the Sale of Radiopharmaceuticals to Hospitals and Clinics, says FTC 5Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... Thoratec Corporation (Nasdaq: THOR ), a ... save, support and restore failing hearts, said today that ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... of International Technidyne Corporation (ITC) to Danaher Corporation ( ...
... Legitimate Medical Equipment Providers Are Victimized by Administrative Backlogs ... , ... recent study by the Government Accountability Office (GAO) confirms that the ... be a problem despite the government,s efforts to implement reforms.  The ...
Cached Medicine Technology:Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation 2GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms 2GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms 3GAO Confirms Payment Delays to Medical Equipment Providers; Questions Arise as to Whether Medicare Can Implement Reforms 4
(Date:4/21/2015)... (PRWEB) April 21, 2015 This ... pathologists, physical therapist assistants, occupational therapist assistants, teachers, ... and techniques to help children across the autism ... through Education Resources Inc. , ... 2008, this highly acclaimed yoga curriculum addresses learning ...
(Date:4/20/2015)... April 21, 2015 When author Faith ... (CFS), she felt as if nothing could wake her up ... that 250,000 U.K. citizens are currently living with CFS. , ... Her new book, “ Living a Life Less Toxic : ... and Environment. Create a Happier, Healthier Life for You, Your ...
(Date:4/20/2015)... Draft, Virginia (PRWEB) April 20, 2015 ... Augusta Health facility in Stuarts Draft, an independent, ... County, Staunton, and Waynesboro, Virginia. The project was ... Architects. The Stuarts Draft facility is expected to ... , Located on Stuarts Draft Highway, the new ...
(Date:4/20/2015)... 21, 2015 Is it possible to create ... relevant to the local needs of the providers, payers and ... was embraced over the past year by the Hutchinson Institute ... Cancer Research Center in Seattle, Washington. , In a new ... The American Journal of Managed Care, HICOR Director Scott ...
(Date:4/20/2015)... The National Association of Professional Women ... Soul Care Group, Inc., as a 2015 Professional Woman ... prestigious distinction for leadership in business. With more than ... the nation's leading networking organizaiton exclusively for professional women. ... of the Year Award,” says NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 3Health News:National Association of Professional Women Announces Susan Binau, Founder of Soul Care Group, Inc., a 2015 Professional Woman of the Year 2
... still tied to geography, race and income, study shows , ... high blood pressure, high blood sugar and are overweight may ... years, a new study finds. , In fact, men may ... be shaving 4.1 years off their lives, the researchers say. ...
... ... of the survivors of the earthquake in Haiti. The Grand Canyon University community has donated ... disaster struck on January 12, 2010. , ... Phoenix, AZ (PRWEB) March 23, 2010 -- Grand Canyon University,s Compassion ...
... ... Teaneck, an independent living community for seniors, has expanded its continuum of care with a ... center is staffed around the clock, seven days a week. The center,s dedicated nurses and ... a compassionate and respectful manner. , ...
... ... , ... ... Being named a Preferred Partner means that Genesis Rehab patients now have access to a comfortable, easy-to-use product ...
... , BRISBANE, Calif. , March 23 ... company,s Marketing Authorization Application (MAA), submitted on March 2 ... pulmonary fibrosis (IPF) in adults, was validated by the European ... indicates that the application is complete and that the review ...
... , ... Record Software Moves to Software-as-a-Service Model , ... (PRWEB) March 23, 2010 -- Healthmaster®, the worldwide leader in ... Online Tech to host their HealthOffice® Software-as-a-Service (Saas) platform in Online Tech’s SAS-70 ...
Cached Medicine News:Health News:Healthy Living Adds Years to Life 2Health News:Healthy Living Adds Years to Life 3Health News:Healthy Living Adds Years to Life 4Health News:Grand Canyon University (GCU) Creates Special Relief Fund and Raises Money for Haiti Earthquake Survivors 2Health News:Classic Residence by Hyatt at Teaneck Opens Licensed Assisted Living Center 2Health News:ReGear Life Sciences Named Preferred Partner to Genesis Rehab Services 2Health News:ReGear Life Sciences Named Preferred Partner to Genesis Rehab Services 3Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 2Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 3Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 4Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 5Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 6Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 7Health News:Online Tech and Healthmaster Sign SaaS Hosting Agreement 2Health News:Online Tech and Healthmaster Sign SaaS Hosting Agreement 3
... The Leica RM2235 is a robust ... of primarily biological specimens embedded in ... backlash-free precision micrometer feed system ensures ... even when sectioning harder tissues. The ...
... Leica SM2000 R sliding microtome with ... section paraffin-embedded samples in routine histopathology ... be used for some specific industrial ... fully equipped to meet most of ...
... CTM 6 is a highly efficient automatic glass ... laboratories. The instrument is capable of coverslipping ... slide rack loading capabilities. The slide baskets are ... each. User intuitive operation is made easy via ...
Hydrophobic Acrylic Intraocular Lens, AC depth: 5.3....
Medicine Products: